• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌中的生态失调协同因子。微生物群如何影响宫颈上皮内瘤变(CIN)的发展。

Dysbiotic Co-Factors in Cervical Cancer. How the Microbiome Influences the Development of Cervical Intraepithelial Neoplasia (CIN).

作者信息

Finzer Patrick, Küppers Volkmar, Griesser Henrik

机构信息

dus.ana Düsseldorf Analytik, Praxis für medizinische Mikrobiologie und Laboratoriumsmedizin, Düsseldorf, Germany.

Institut für Medizinische Mikrobiologie und Krankenhaushygiene, Heinrich-Heine Universität Düsseldorf, Düsseldorf, Germany.

出版信息

Geburtshilfe Frauenheilkd. 2023 May 4;83(8):1017-1021. doi: 10.1055/a-2044-0162. eCollection 2023 Aug.

DOI:10.1055/a-2044-0162
PMID:37588255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10427202/
Abstract

Human papillomavirus (HPV) infection is a necessary but not sufficient condition for the development of cervical cancer. The dysbiotic shift in the cervicovaginal microbiome appears to be a major co-factor in carcinogenesis. New analytical methods, such as next-generation sequencing (NGS), can be used to detect all of the vaginal microorganisms present and therefore identify individual therapeutic options. The relationship of bacterial vaginosis and carcinogenesis, as well as possible indications for the use of microbiome analysis, will be discussed.

摘要

人乳头瘤病毒(HPV)感染是宫颈癌发生的必要但非充分条件。宫颈阴道微生物群的生态失调转变似乎是致癌过程中的一个主要协同因素。新的分析方法,如下一代测序(NGS),可用于检测所有存在的阴道微生物,从而确定个体化治疗方案。本文将讨论细菌性阴道病与致癌作用的关系,以及微生物群分析可能的应用指征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5472/10427202/8562c8a7a483/10-1055-a-2044-0162_20504412.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5472/10427202/8f8cfad97447/10-1055-a-2044-0162_20620656.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5472/10427202/8562c8a7a483/10-1055-a-2044-0162_20504412.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5472/10427202/8f8cfad97447/10-1055-a-2044-0162_20620656.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5472/10427202/8562c8a7a483/10-1055-a-2044-0162_20504412.jpg

相似文献

1
Dysbiotic Co-Factors in Cervical Cancer. How the Microbiome Influences the Development of Cervical Intraepithelial Neoplasia (CIN).宫颈癌中的生态失调协同因子。微生物群如何影响宫颈上皮内瘤变(CIN)的发展。
Geburtshilfe Frauenheilkd. 2023 May 4;83(8):1017-1021. doi: 10.1055/a-2044-0162. eCollection 2023 Aug.
2
Cervicovaginal Microbiome after Cervical Intraepithelial Neoplasia Treatment. A Protocol for Systematic Review and Meta-Analysis.宫颈上皮内瘤变治疗后宫颈阴道微生物组。系统评价和荟萃分析方案。
Int J Environ Res Public Health. 2021 Aug 27;18(17):9050. doi: 10.3390/ijerph18179050.
3
The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer.宫颈阴道和肠道微生物群在宫颈上皮内瘤变和宫颈癌中的作用
J Immunother Precis Oncol. 2020 Sep 14;4(2):72-78. doi: 10.36401/JIPO-20-17. eCollection 2021 May.
4
Human Papillomavirus Infections and the Role Played by Cervical and Cervico-Vaginal Microbiota-Evidence from Next-Generation Sequencing Studies.人乳头瘤病毒感染以及宫颈和宫颈阴道微生物群所起的作用——来自新一代测序研究的证据
Cancers (Basel). 2024 Jan 17;16(2):399. doi: 10.3390/cancers16020399.
5
Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort.人乳头瘤病毒感染和宫颈上皮内瘤变进展与中国队列中阴道微生物组多样性增加相关。
BMC Infect Dis. 2020 Aug 26;20(1):629. doi: 10.1186/s12879-020-05324-9.
6
Vaginal Microbiota and Cytokine Microenvironment in HPV Clearance/Persistence in Women Surgically Treated for Cervical Intraepithelial Neoplasia: An Observational Prospective Study.阴道微生物群和细胞因子微环境在接受宫颈上皮内瘤变手术治疗的女性HPV清除/持续感染中的作用:一项前瞻性观察研究
Front Cell Infect Microbiol. 2020 Nov 5;10:540900. doi: 10.3389/fcimb.2020.540900. eCollection 2020.
7
Species-level characterization of the cervicovaginal microbiota and its role in human papillomavirus-associated cervical carcinogenesis.宫颈阴道微生物群的种水平特征及其在人乳头瘤病毒相关宫颈癌发病机制中的作用。
J Med Virol. 2024 Jun;96(6):e29764. doi: 10.1002/jmv.29764.
8
Co-infection with trichomonas vaginalis increases the risk of cervical intraepithelial neoplasia grade 2-3 among HPV16 positive female: a large population-based study.阴道毛滴虫合并感染增加 HPV16 阳性女性宫颈上皮内瘤变 2-3 级的风险:一项大型基于人群的研究。
BMC Infect Dis. 2020 Sep 1;20(1):642. doi: 10.1186/s12879-020-05349-0.
9
Clinical characteristics, HPV involvement, and demographic risk factors in women with cervical intraepithelial neoplasia complicated by vaginal intraepithelial neoplasia.宫颈上皮内瘤变合并阴道上皮内瘤变患者的临床特征、HPV 感染及人口统计学危险因素。
BMC Womens Health. 2024 Apr 4;24(1):220. doi: 10.1186/s12905-024-03030-1.
10
Influence of co-infection complicated with human papillomavirus on cervical intraepithelial neoplasia development in patients with atypical squamous cells of undetermined significance.人乳头瘤病毒合并感染对意义不明确的非典型鳞状细胞患者宫颈上皮内瘤变发展的影响。
J Infect Chemother. 2017 Dec;23(12):814-819. doi: 10.1016/j.jiac.2017.08.008. Epub 2017 Oct 12.

引用本文的文献

1
Insights into the tripartite relationship between cervical cancer, human papillomavirus, and the vaginal microbiome: a mega-analysis.宫颈癌、人乳头瘤病毒与阴道微生物群三方关系的见解:一项荟萃分析
Hum Genomics. 2025 Aug 12;19(1):89. doi: 10.1186/s40246-025-00795-w.
2
ATP13A2 as a prognostic biomarker and its correlation with immune infiltration in cervical cancer: A retrospective study.ATP13A2作为宫颈癌的预后生物标志物及其与免疫浸润的相关性:一项回顾性研究。
J Cell Mol Med. 2025 Apr;29(7):e70097. doi: 10.1111/jcmm.70097.
3
Molecular aspects of cervical cancer: a pathogenesis update.

本文引用的文献

1
Sub-communities of the vaginal microbiota in pregnant and non-pregnant women.孕妇和非孕妇阴道微生物群的亚群。
Proc Biol Sci. 2023 Nov 29;290(2011):20231461. doi: 10.1098/rspb.2023.1461.
2
Emu: species-level microbial community profiling of full-length 16S rRNA Oxford Nanopore sequencing data.鸸鹋:全长 16S rRNA Oxford Nanopore 测序数据的种水平微生物群落分析。
Nat Methods. 2022 Jul;19(7):845-853. doi: 10.1038/s41592-022-01520-4. Epub 2022 Jun 30.
3
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy.
宫颈癌的分子学研究进展:发病机制的最新情况
Front Oncol. 2024 Mar 19;14:1356581. doi: 10.3389/fonc.2024.1356581. eCollection 2024.
子宫颈癌的诊断、治疗与随访。德国妇科与产科学会(DGGG)、德国妇科肿瘤学会(DKG)和德国妇科与产科学会健康保险分会(DKH)指南(S3级,德国医学科学院质量与效率医学研究所登记号:032/033OL,2021年5月)——第1部分:关于流行病学、筛查、诊断与治疗的建议
Geburtshilfe Frauenheilkd. 2022 Feb 11;82(2):139-180. doi: 10.1055/a-1671-2158. eCollection 2022 Feb.
4
A systematic review and meta-analysis on the efficacy of probiotics for bacterial vaginosis.一项关于益生菌治疗细菌性阴道病疗效的系统评价和荟萃分析。
Eur Rev Med Pharmacol Sci. 2022 Jan;26(1):90-98. doi: 10.26355/eurrev_202201_27752.
5
Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection.宫颈阴道微生物群因素与人乳头瘤病毒感染清除情况
Front Oncol. 2021 Jul 28;11:722639. doi: 10.3389/fonc.2021.722639. eCollection 2021.
6
VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition.基于组成的阴道微生物群落最近质心分类方法(VALENCIA)
Microbiome. 2020 Nov 23;8(1):166. doi: 10.1186/s40168-020-00934-6.
7
Anti-tumor activities of probiotics in cervical cancer.益生菌在宫颈癌中的抗肿瘤活性。
J Ovarian Res. 2020 Jun 11;13(1):68. doi: 10.1186/s13048-020-00668-x.
8
Microbiome factors in HPV-driven carcinogenesis and cancers.人乳头瘤病毒驱动的致癌作用及癌症中的微生物群因素
PLoS Pathog. 2020 Jun 4;16(6):e1008524. doi: 10.1371/journal.ppat.1008524. eCollection 2020 Jun.
9
Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.随机试验表明,Lactin-V 可预防细菌性阴道病复发。
N Engl J Med. 2020 May 14;382(20):1906-1915. doi: 10.1056/NEJMoa1915254.
10
Cervicovaginal microbiome and natural history of HPV in a longitudinal study.宫颈阴道微生物组与 HPV 的纵向研究自然史。
PLoS Pathog. 2020 Mar 26;16(3):e1008376. doi: 10.1371/journal.ppat.1008376. eCollection 2020 Mar.